Related Experiment Videos
Factor VIII activity in chronic renal disease
Insights
Levels of Factor VIII (F VIII) coagulant, antigen, and cofactor activity were elevated in patients with chronic kidney disease. This increase, linked to early renal damage, diminished in terminal renal failure due to uremia.
Area of Science:
- Nephrology
- Hematology
- Clinical Biochemistry
Background:
- Chronic kidney disease (CKD) affects multiple organ systems.
- Coagulation factor abnormalities are observed in CKD patients.
- Factor VIII (F VIII) is a key protein in the coagulation cascade.
Purpose of the Study:
- To investigate the levels of F VIII coagulant, F VIII-related antigen, and F VIII ristocetin cofactor activity in patients with various chronic renal diseases.
- To explore the relationship between F VIII levels and renal insufficiency, including different stages of CKD.
Main Methods:
- Measurement of F VIII coagulant activity.
- Measurement of F VIII-related antigen.
- Measurement of F VIII ristocetin cofactor activity.
- Correlation analysis with serum creatinine levels and clinical parameters in 68 CKD patients.
Main Results:
- Significantly increased F VIII coagulant, antigen, and cofactor activity were observed in CKD patients.
- A strong correlation between F VIII activities and serum creatinine was found in mild to moderate renal insufficiency (glomerulonephritis, kidney transplants).
- This correlation was absent in patients with terminal renal failure.
Conclusions:
- Elevated F VIII levels in early-stage CKD may be linked to glomerular endothelial damage.
- In terminal renal failure, increased F VIII concentrations likely result from non-specific uremia-related factors, such as acute phase reactions.
Abstract:
F VIII coagulant, F VIII-related antigen and F VIII ristocetin cofactor activity were significantly increased in 68 patients with various chronic renal diseases. All three F VIII functions correlated generally well with each other. A striking relationship between some F VIII activities and serum creatinine was detectable in patients with glomerulonephritis and kidney transplants, with mild or moderate renal insufficiency. This correlation was no longer present in terminal renal failure. The results suggest that in initial stages of renal disease elevated F VIII levels may be attributable to glomerular endothelial damage. In terminal renal failure, however, increased F VIII concentrations seem to result from nonspecific causes related to uremia such as acute phase reactions.